Donor Alliance Company Profile

Background

Overview

Donor Alliance is a non-profit organization dedicated to saving and healing lives through organ and tissue donation and transplantation. Serving Colorado and most of Wyoming, it operates as the federally designated Organ Procurement Organization (OPO) and is accredited by the American Association of Tissue Banks (AATB). The organization collaborates with over 100 hospitals to facilitate the donation and recovery of transplantable organs and tissues.

Mission and Vision

Mission: To save and heal lives through organ and tissue donation and transplantation.

Vision: Maximizing all donation opportunities.

Industry Significance

As one of 56 federally designated OPOs in the United States, Donor Alliance plays a critical role in the national organ and tissue donation network, contributing to the high donor registration rates in Colorado and Wyoming. These efforts directly translate to more lives saved and healed through transplantation.

Key Strategic Focus

Core Objectives

Increase organ and tissue donor registrations.

Enhance partnerships with hospitals to maximize donation opportunities.

Educate the public on the benefits of organ and tissue donation.

Areas of Specialization

Organ and tissue donation and transplantation.

Public education and outreach.

Hospital partnerships and support.

Key Technologies Utilized

Microsoft Azure Cloud Services for application hosting and computing.

Microsoft 365 for collaboration.

New Relic APM for application performance management.

Primary Markets Targeted

Residents of Colorado and Wyoming.

Hospitals and healthcare providers within the service area.

Financials and Funding

Funding History

As a non-profit organization, Donor Alliance's funding primarily comes from reimbursement fees for organ and tissue recovery, grants, and donations. In 2024, the organization reported total revenues of $71,594,779 and expenses of $65,506,168.

Recent Funding Rounds

Specific details about recent funding rounds are not publicly disclosed.

Notable Investors

As a non-profit, Donor Alliance does not have investors but receives support from various foundations and donors.

Utilization of Capital

The capital is utilized to support organ and tissue recovery operations, public education campaigns, hospital partnerships, and community outreach programs.

Pipeline Development

Key Pipeline Candidates

As an OPO, Donor Alliance does not develop pharmaceutical or medical device products but focuses on facilitating organ and tissue donations.

Stages of Development

The organization operates in the implementation and operational stages, focusing on the recovery and transplantation of organs and tissues.

Target Conditions

Donor Alliance addresses the need for organ and tissue transplants for various conditions, including:

End-stage organ failure.

Trauma-related injuries.

Degenerative diseases.

Anticipated Milestones

Increasing donor registration rates.

Enhancing organ and tissue recovery rates.

Expanding public education and outreach efforts.

Technological Platform and Innovation

Proprietary Technologies

Donor Alliance utilizes proprietary systems for managing donor information, coordinating with hospitals, and tracking organ and tissue recovery processes.

Significant Scientific Methods

Data analytics for matching donors with recipients.

Public education campaigns to increase donor registrations.

Leadership Team

Executive Profiles

Jennifer Prinz, RN, MPH, CPTC, CTBS – President and Chief Executive Officer. Jennifer has extensive experience in organ and tissue donation, leading Donor Alliance since 2017.

Jennifer Muriett, RN, MSN, CPTC – Chief Operating Officer. Jennifer oversees the organization's operations, ensuring efficient and effective donation processes.

Matt Lovetro, CPA, CGM – Chief Financial Officer. Matt manages the financial aspects of Donor Alliance, ensuring fiscal responsibility and sustainability.

Laura Jeffries, SPHR, SHRM-SCP – Vice President of Human Resources. Laura leads the human resources department, focusing on employee engagement and organizational development.

Competitor Profile

Market Insights and Dynamics

The organ and tissue donation sector is characterized by a network of federally designated OPOs, each serving specific geographic regions. The market is influenced by factors such as donor registration rates, public awareness, and healthcare infrastructure.

Competitor Analysis

Southwest Transplant Alliance (STA): Serving Texas, STA is one of the largest OPOs, managing over 280 hospitals and 11 transplant centers.

OneLegacy: Based in California, OneLegacy is a leading OPO serving the greater Los Angeles area.

Gift of Hope Organ and Tissue Donor Network: Serving Illinois, Gift of Hope is one of the largest OPOs in the U.S.

Strategic Collaborations and Partnerships

Donor Alliance collaborates with hospitals, healthcare providers, and community organizations to enhance donation and transplantation efforts. The organization also partners with the Donate Life America network to promote donor registration.

Operational Insights

Donor Alliance's strategic focus on public education and hospital partnerships differentiates it from competitors, contributing to higher donor registration rates in its service area.

Strategic Opportunities and Future Directions

Strategic Roadmap

Expand Public Education: Enhance outreach programs to increase donor registrations.

Strengthen Hospital Partnerships: Collaborate with more healthcare facilities to improve donation rates.

Leverage Technology: Implement advanced data analytics to optimize matching processes.

Future Business Directions

Donor Alliance aims to increase the number of organ and tissue donors, improve recovery rates, and expand its public education initiatives to save and heal more lives.